- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04318821
Effect of Laser Acupuncture on Adhesive Small Bowel Obstruction
March 8, 2022 updated by: Chang Gung Memorial Hospital
Effect of Laser Acupuncture on Adhesive Small Bowel Obstruction: a Prospective Double-blind Randomized Controlled Trial
Adhesive small bowel obstruction (ASBO) is one of the most common complications and is a major cause of admission after intra-abdominal surgery.
To date, the ideal management of ASBO remains controversial.
The aim of this protocol designed as a double-blind randomized controlled trial is to investigate the efficacy of laser acupuncture (LA) therapy in patients with ASBO.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
92
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chun-Ting Liu, MD
- Phone Number: 2334 +886-7-7317123
- Email: juntin0214@gmail.com
Study Locations
-
-
-
Kaohsiung, Taiwan, 833
- Recruiting
- Kaohsiung Chang Gung Memorial Hospital
-
Contact:
- Chun-Ting Liu, MD
- Phone Number: 2334 +886-7-7317123
- Email: juntin0214@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 20 to 80 years
- Clinical symptoms and signs of mechanical obstruction
Exclusion Criteria:
- Clear non-adhesive etiology of small bowel obstruction (e.g. tumor, hernia)
- Emergency surgical intervention before being admitted to the hospital
- Pregnancy
- Local skin infection on the acupoints, and limb amputees.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Control group
The subjects in the control group will receive sham LA treatment, without any laser output (no stimulation) at the same acupoints used in experimental group.
|
Laser acupuncture is a non-invasive therapy that involves stimulation of traditional acupoints with low-intensity, non-thermal laser irradiation.
|
|
Experimental: LA group
The subjects in the experimental group will receive 0.375 J of energy at each of the following acupoints: LI4 (Hegu, B3), PC6 (Neiguan, B3), ST25 (Tianshu, B3), ST36 (Zusanli, B2), CV4 (Guanyuan), CV12 (Zhongwan, B3).
|
Laser acupuncture is a non-invasive therapy that involves stimulation of traditional acupoints with low-intensity, non-thermal laser irradiation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success rate of conservative treatment
Time Frame: 2 week
|
Defined as no need for long term nasogastric tube decompression and operative intervention.
|
2 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to oral intake
Time Frame: 2 weeks
|
Defined as participants can try intake due to symptoms improved including nausea, vomiting, distension and pain.
|
2 weeks
|
|
Length of hospital stay
Time Frame: Through study completion, an average of 1 year
|
Date from admission to discharge
|
Through study completion, an average of 1 year
|
|
Serum lipase
Time Frame: Up to 2 weeks
|
Serum lipase
|
Up to 2 weeks
|
|
Serum amylase
Time Frame: Up to 2 weeks
|
Serum amylase
|
Up to 2 weeks
|
|
Serum cortisol
Time Frame: Up to 2 weeks
|
Serum cortisol
|
Up to 2 weeks
|
|
Serum motilin
Time Frame: Up to 2 weeks
|
Serum motilin
|
Up to 2 weeks
|
|
Serum ghrelin
Time Frame: Up to 2 weeks
|
Serum ghrelin
|
Up to 2 weeks
|
|
Serum intestinal fatty acid binding protein (I-FABP)
Time Frame: Up to 2 weeks
|
Serum intestinal fatty acid binding protein (I-FABP)
|
Up to 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chun-Ting Liu, MD, Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2020
Primary Completion (Anticipated)
February 28, 2023
Study Completion (Anticipated)
February 28, 2023
Study Registration Dates
First Submitted
March 16, 2020
First Submitted That Met QC Criteria
March 22, 2020
First Posted (Actual)
March 24, 2020
Study Record Updates
Last Update Posted (Actual)
March 10, 2022
Last Update Submitted That Met QC Criteria
March 8, 2022
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMRPG8K0571
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adhesive Small Bowel Obstruction
-
Almazov National Medical Research CentreNot yet recruitingAdhesive Small Bowel ObstructionRussia
-
University of WashingtonEnrolling by invitationAdhesive Small Bowel ObstructionUnited States
-
Helsinki University Central HospitalUnknownAdhesive Small Bowel ObstructionFinland, Italy
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingAdhesive Small Bowel ObstructionUnited States
-
Uppsala UniversityCompletedAdhesive Small Bowel Obstruction
-
Uppsala UniversityCompletedAdhesive Small Bowel Obstruction
-
University of California, Los AngelesRecruitingAdhesive Small Bowel ObstructionUnited States
-
Radboud University Medical CenterBaxter Healthcare Corporation; ZonMw: The Netherlands Organisation for Health... and other collaboratorsNot yet recruitingAdhesive Small Bowel ObstructionBelgium, Netherlands
-
Alessio GiordanoPlantTec Medical GmbHNot yet recruitingBowel Obstruction | Adhesive Small Bowel Obstruction | Postoperative Abdominal Adhesions | Abdominal Surgery Complications
-
The First Affiliated Hospital with Nanjing Medical...CompletedSmall Bowel Obstruction | Small Bowel Obstruction AdhesionChina
Clinical Trials on Laser acupuncture
-
Kuang Tien General HospitalRecruiting
-
China Medical University HospitalNot yet recruiting
-
Reproductive Medicine Associates of New JerseyCompletedEmbryo ImplantationUnited States
-
Indonesia UniversityCompleted
-
China Medical University HospitalEnrolling by invitationAge-related Macular DegenerationTaiwan
-
Chang Gung Memorial HospitalCompletedKnee OsteoarthritisTaiwan
-
Taiwan Municipal An-Nan Hospital-China Medical...Recruiting
-
Indonesia UniversityCompletedChronic Pulmonary ObstructionIndonesia
-
Chang Gung Memorial HospitalEnrolling by invitationCarpal Tunnel Syndrome | Acupuncture | Laser AcupunctureTaiwan